Patungan, Nahda M.
HRN: 21-13-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2024
CEFTRIAXONE 1G (VIAL)
01/07/2024
01/13/2024
IVTT
2g
OD
Acute Pyelonephritis; R/o Surgical Abdomen
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes